CHARLES MALIS: Open Payments
NPI 1891766176 · MASHPEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 9 companies in 2025. Trend: 2023 $193 · 2024 $144 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Braeburn Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
| Orexo US, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Kerendia, BRIXADI, YUPELRI, Cologuard Collection Kit, Zubsolv, The Cologuard Plus Collection Kit, SUBLOCADE, GEMTESA.
Industry payments across MA — which companies pay providers there.
